The closing price of Genius Sports Limited (NYSE: GENI) was $5.60 for the day, down -5.56% from the previous closing price of $5.93. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 1745657 shares were traded.
Ratios:
Our analysis of GENI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 105.91. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 1.34. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 21, 2023, Macquarie started tracking the stock assigning a Outperform rating and target price of $11.
On October 12, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.Cantor Fitzgerald initiated its Overweight rating on October 12, 2023, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GENI now has a Market Capitalization of 1.24B and an Enterprise Value of 1.16B. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.90 while its Price-to-Book (P/B) ratio in mrq is 2.04. Its current Enterprise Value per Revenue stands at 2.81 whereas that against EBITDA is 205.26.
Stock Price History:
Over the past 52 weeks, GENI has reached a high of $8.45, while it has fallen to a 52-week low of $3.55. The 50-Day Moving Average of the stock is 6.49, while the 200-Day Moving Average is calculated to be 6.12.
Shares Statistics:
GENI traded an average of 2.32M shares per day over the past three months and 2.58M shares per day over the past ten days. A total of 209.12M shares are outstanding, with a floating share count of 156.13M. Insiders hold about 27.65% of the company’s shares, while institutions hold 57.09% stake in the company. Shares short for GENI as of Mar 15, 2024 were 5.92M with a Short Ratio of 2.47, compared to 5.1M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.82% and a Short% of Float of 3.85%.
Earnings Estimates
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.12, while EPS last year was -$0.12. The consensus estimate for the next quarter is -$0.03, with high estimates of $0 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.05 and -$0.25 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.03, with 9 analysts recommending between $0.1 and -$0.16.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 10 analysts. It ranges from a high estimate of $117.7M to a low estimate of $114.97M. As of the current estimate, Genius Sports Limited’s year-ago sales were $97.23M, an estimated increase of 20.20% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $94.09M, an increase of 8.30% less than the figure of $20.20% in the same quarter last year. There is a high estimate of $95M for the next quarter, whereas the lowest estimate is $91.02M.
A total of 10 analysts have provided revenue estimates for GENI’s current fiscal year. The highest revenue estimate was $483.6M, while the lowest revenue estimate was $479.05M, resulting in an average revenue estimate of $480.87M. In the same quarter a year ago, actual revenue was $412.98M, up 16.40% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $555.25M in the next fiscal year. The high estimate is $566.9M and the low estimate is $544.07M. The average revenue growth estimate for next year is up 15.50% from the average revenue estimate for this year.
